The future mRNA workforce

The new industry of mRNA needs a highly skilled specialised workforce.

Monash Centre for Advanced mRNA Medicines Manufacturing and Workforce Training

The Victorian Government has invested $10 million through mRNA Victoria for Monash University to establish the Monash Centre for Advanced mRNA Medicines Manufacturing and Workforce Training.

The Centre provides training for the mRNA workforce for the Asia-Pacific region in all aspects of the mRNA pipeline including:

• Research and development
• Clinical Trials
• Regulatory Approval
• Production scale-up and manufacturing.

The Australian Centre for AI in Medical Innovation (ACAMI)

To build the mRNA industry in Victoria, mRNA Victoria collaborates with partners across the ecosystem including research institutes, start-ups, venture capitalists, and established industry players.

mRNA Victoria has partnered with La Trobe University to launch the Australian Centre for AI in Medical Innovation, ACAMI.

ACAMI brings together world-leading experts in artificial intelligence and medical research to change the way we diagnose and treat cancer, infectious diseases, and cardiovascular disease.

Researchers at the Centre will use artificial intelligence to advance medical research, develop workforce capabilities and improve clinical trials – uncovering new treatments, vaccines and immunotherapies for cancers, diseases and viruses.

Combining La Trobe’s artificial intelligence researchers with existing medical research capabilities, ACAMI works with collaboration partners like the Olivia Newton John Cancer Research Institute to develop new diagnostic tools and treatment options for patients.

In May 2025, mRNA Victoria, in collaboration with La Trobe, switched on ACAMI’s new NVIDIA DGX H200 AI supercomputer, which is one of the fastest in Australia and positions Victoria as a national hub for AI in medical innovation.

The first deployment of its kind at a university in Australia, the supercomputer will use AI to accelerate the translation of research into clinical trials and personalised therapies to improve health outcomes for patients.

This groundbreaking technology will support our world-leading researchers to accelerate medical innovations in the state – cementing Victoria’s reputation as a global leader in this field.

For more information about mRNA Victoria and our investment in training the future mRNA workforce, please contact us via email mRNAvictoria@ecodev.vic.gov.au or follow us on LinkedIn.